Novel water-soluble analogues retaining potent antitumor activity of RA-VII, a cyclic hexapeptide from Rubia plants
- 16 December 1997
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (24), 3125-3128
- https://doi.org/10.1016/s0960-894x(97)10157-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inhibition of Protein Synthesis by RA-VIIBioorganic Chemistry, 1995
- An Efficient Backbone Amide Nitrogen Alkylation of RA-VII, an Antitumor Cyclic HexapeptideChemistry Letters, 1993
- Studies on RA Derivatives. V. Synthesis and Antitumor Activity of Ala2-Modified RA-VII Derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1993
- New antitumor bicyclic hexapeptides, RA-XI, -XII, -XIII and -XIV from Rubia cordifolia.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Studies on antitumor cyclic hexapeptides RA obtained from Rubiae Radix, Rubiaceae. III. On derivatives of RA-V and their in vivo activities.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Solution forms of bouvardin and relatives from NMR studies. 6-O-MethylbouvardinJournal of the American Chemical Society, 1983
- Studies on the antitumor cyclic hexapeptides obtained from Rubiae radix.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- The mode of action of the antitumor drug bouvardin, an inhibitor of protein synthesis in eukaryotic cellsFEBS Letters, 1982
- Bouvardin and deoxybouvardin, antitumor cyclic hexapeptides from Bouvardia ternifolia (Rubiaceae)Journal of the American Chemical Society, 1977